An improved approach for testing gravitational redshift via spacecraft based three frequency links combination

Author(s):  
Ziyu Shen ◽  
Wen-Bin Shen ◽  
Lin He ◽  
Tengxu Zhang ◽  
Zhan Cai

<p>We propose a new approach for testing the gravitational redshift based on frequency signals transmission between a spacecraft and a ground station. By a combination of one uplink signal and two downlink signals, the gravitational redshift can be tested at about 6.5×10<sup>-6</sup> level for a GNSS satellite (the signals’ frequencies are about 1.2~1.6 GHz), and about 2.2×10<sup>-6</sup> level for the International Space Station (the signals’ frequencies are up to 14.7 GHz), under the assumption that the clock accuracy is about 10<sup>-17</sup> level. For better desinged cases the accuracy of gravitational redshift test can be improved to several parts in 10<sup>-8</sup> level (the signals’ frequencies are about 8~12 GHz). Compared to the scheme of Gravity Probe-A (GP-A) experiment conducted in1976, the new approach does not require any onboard signal transponders, and the frequency values of the three links can be quite arbitrarily given. As the hardware requirement is reduced, a number of spacecrafts could be chosen as candidates for a gravitational redshift experiment. This approach could also be used in gravitational potential determination, which has prospective applications in geodesy. This study is supported by National Natural Science Foundation of China (NSFC) (grant Nos. 42030105, 41721003, 41631072, 41874023, 41804012), Space Station Project (2020)228, and Natural Science Foundation of Hubei Province(grant No. 2019CFB611).</p>

2020 ◽  
Vol 91 (1) ◽  
pp. 41-45 ◽  
Author(s):  
Virginia. E. Wotring ◽  
LaRona K. Smith

INTRODUCTION: There are knowledge gaps in spaceflight pharmacology with insufficient in-flight data to inform future planning. This effort directly addressed in-mission medication use and also informed open questions regarding spaceflight-associated changes in pharmacokinetics (PK) and/or pharmacodynamics (PD).METHODS: An iOS application was designed to collect medication use information relevant for research from volunteer astronaut crewmembers: medication name, dose, dosing frequency, indication, perceived efficacy, and side effects. Leveraging the limited medication choices aboard allowed a streamlined questionnaire. There were 24 subjects approved for participation.RESULTS: Six crewmembers completed flight data collection and five completed ground data collection before NASA’s early study discontinuation. There were 5766 medication use entries, averaging 20.6 ± 8.4 entries per subject per flight week. Types of medications and their indications were similar to previous reports, with sleep disturbances and muscle/joint pain as primary drivers. Two subjects treated prolonged skin problems. Subjects also used the application in unanticipated ways: to note drug tolerance testing or medication holiday per research protocols, and to share data with flight surgeons. Subjects also provided usability feedback on application design and implementation.DISCUSSION: The volume of data collected (20.6 ± 8.4 entries per subject per flight week) is much greater than was collected previously (<12 per person per entire mission), despite user criticisms regarding app usability. It seems likely that improvements in a software-based questionnaire application could result in a robust data collection tool that astronauts find more acceptable, while simultaneously providing researchers and clinicians with useful data.Wotring VE, Smith LK. Dose tracker application for collecting medication use data from International Space Station crew. Aerosp Med Hum Perform. 2020; 91(1):41–45.


Sign in / Sign up

Export Citation Format

Share Document